Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07124208) titled 'A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes' on Aug. 4.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: First Institute of All Medicines
Condition:
Type 2 Diabetes
Intervention:
Device: Biophoton Generators
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: August 8, 2025
Target Sample Size: 46
Countries of Recruitment:
Uni...